Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis Interventions: Drug: IVIEW-1201; Drug: Ofloxacin Eye Drops Sponsor: IVIEW Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Conjunctivitis | Research